Humaanfibrinogeeni ostmine

One-sentence business summary
“Rakvere Hospital is running a 12-month mandatory-supply tender for human fibrinogen (no Russian/Belarusian firms allowed) where the only gate-to-bid is completing Annex 1 with the exact unit price (€, 2 decimals, ex-VAT) that matches the e-procurement form and certifying the product is not under international sanctions—no further technical/quality criteria disclosed—so any EU-sourced fibrinogen supplier that can deliver steady hospital-grade stock for a year and meet these simple compliance checks should bid.”

Rakvere Haigla otsib 12 kuuks tarnijat humaanfibrinogeenile, kus ainsaks hindamiskriteeriumiks (100 %) on ilma käibemaksuta eurodes esitatav MADALAIM ÜHIKHIND (ühik 80 EUR); tehnilised nõuded on kirjas Lisa 1-s, vene või valgevene ettevõtjaid ei lubata ja hanke võidab odavaim aus pakkumus.

Rakvere Hospital seeks a 12-month supplier of human fibrinogen (mandatory pharmaceutical-grade product) and will exclude any bidder located in Russia or Belarus; no detailed technical, financial or experience criteria are disclosed in this ESPD-only notice, so firms should await full tender documents to confirm compliance before deciding to bid.

Rakvere Hospital seeks a 12-month supply (70–80 vials) of human fibrinogen (ATC B02BB01) 1 g powder + solvent, requiring mandatory Estonian/English SPC on request, 72-hour delivery to Rakvere, cold-chain compliance, 1-piece minimum orders, fixed unit price for the full contract period, and bidders must not be located in Russia or Belarus.

One-year (mandatory) supply contract for human fibrinogen to Rakvere Hospital; bidders must be EU-based (Russian/Belarusian firms excluded) and will be evaluated on compliance with the technical requirements stated in the procurement documents.

Rakvere Hospital (AS) is running a simplified, 12-month open procurement for human fibrinogen (medicines CPV) with mandatory delivery terms set out in the tender documents, open only to suppliers not located in Russia or Belarus, and the buyer may convert the procedure to a negotiated process or reject all offers.